反应详情

Following general procedure D, {6-bromo-4-[4-(pyrrolidin-1-ylmethyl)piperidin-1-yl]quinolin-3-yl}(cyclopropyl)methanone (26 mg, 0.059 mmol) was reacted with 2-fluoro-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (32 mg, 0.118 mmol) to afford the desired product (15.4 mg, 52%) as a gray solid: 1H NMR (500 MHz, CD3OD) δ 8.78 (s, 1H), 8.27 (s, 1H), 8.03 (s, 2H), 7.23-7.04 (m, 2H), 3.99 (s, 3H), 3.54 (d, J=12.8 Hz, 2H), 3.28-3.11 (m, 6H), 3.05 (d, J=6.6 Hz, 2H), 2.63-2.51 (m, 1H), 2.20-1.89 (m, 7H), 1.80-1.58 (m, 2H), 1.41-1.16 (m, 4H).